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PEALTH POLICY
ealth Insurance and Cardiac Transplantation
Call for Reform
ouise P. King, JD,* Laura A. Siminoff, PHD,† Dan M. Meyer, MD,‡ Clyde W. Yancy, MD,§
. Steves Ring, MD,‡ Thomas W. Mayo, JD, Mark H. Drazner, MD, MSC*§
allas, Texas; and Cleveland, Ohio
Cardiac transplantation is an accepted therapy for patients with end-stage heart failure
(ESHF). Presently in the U.S., patients with ESHF need to have health insurance or another
funding source to be considered eligible for cardiac transplantation. Whether it is appropriate
to exclude potential recipients solely due to lack of finances has received considerable interest
including being the subject of a recent major motion picture (John Q, New Line Cinema,
2002). However, one important aspect of this debate has been underappreciated and
insufficiently addressed. Specifically, organ donation does not require the donor to have health
insurance. Thus, individuals donate their hearts although they themselves would not have
been eligible to receive a transplant had they needed one. By querying Siminoff’s National
Study of Family Consent to Organ Donation database, we find that this situation is not
uncommon as 23% of organ donors are uninsured. Herein we also discuss how the funding
requirement for cardiac transplantation has been addressed by the federal government in the
past, its implications on the organ donor consent process, and its potential impact on organ
donation rates. We call for a government-sponsored, multidisciplinary task force to address
this situation in hopes of remedying the inequities in the present system of organ
allocation. (J Am Coll Cardiol 2005;45:1388–91) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.01.032Cardiology Foundation
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tmiddle-aged African American woman was rehospital-
zed with refractory end-stage heart failure (ESHF). She
as known to have a nonischemic cardiomyopathy with
everely depressed left ventricular ejection fraction and
evere mitral regurgitation. Via right-sided heart catheteriza-
ion, she was documented to be in cardiogenic shock with a
ardiac index of 0.9 l/min/m2 and a mixed venous saturation of
6%. She was dependent upon inotropic therapy and was
elt too ill for repair of her mitral valve. Her attending
ardiologist noted the urgent need for cardiac transplanta-
ion. She had no private insurance, and her income made
er ineligible for public insurance despite a long history of
teady employment. Therefore, she was not evaluated for
ransplantation, as it was known that she could not be listed
or a transplant in the absence of funding for the procedure.
ver several weeks, her condition continued to deteriorate
espite maximal medical therapy and she was made “do not
esuscitate” at her request before expiring. The hospital
ischarge note included the following statement, “All at-
empts at transplant were thwarted by lack of funding.”
From the *Donald W. Reynolds Cardiovascular Clinical Research Center, §Divi-
ion of Cardiology, Department of Internal Medicine, and ‡Department of Cardio-
ascular and Thoracic Surgery, University of Texas Southwestern Medical Center,
allas, Texas; Dedman School of Law, Southern Methodist University, Dallas,
exas; and †Case Western Reserve University, Cleveland, Ohio. Louise King and Dr.
razner were supported by the Donald W. Reynolds Cardiovascular Clinical
esearch Center, Dallas, Texas, and by the Doris Duke Charitable Foundation, New
ork, New York. Dr. Siminoff was supported by the Agency for Health Research and
uality (AHRQ), grant # R01-HS08209.t
Manuscript received October 6, 2004; revised manuscript received January 4, 2005,
ccepted January 11, 2005.NTRODUCTION
n our heart failure clinic in an urban public hospital, we
ave encountered a number of low-income patients with
SHF who do not have health insurance (1). As illustrated
n the above case report, cardiac transplantation, a widely
ccepted but expensive therapy for ESHF, is not generally
vailable in the U.S. to those who do not have health
nsurance, as such patients usually do not have the financial
herewithal to pay for the procedure and its associated
osts. Whether it is appropriate for a potential recipient’s
ocioeconomic status (SES) to be a factor in the allocation
f donated organs has received attention from the federal
overnment (2) and, more recently, the film industry in the
ajor motion picture John Q (New Line Cinema, 2002).
owever, we believe one important aspect of this debate has
een underappreciated and insufficiently addressed. Specif-
cally, organ donation does not require the donor to have
ealth insurance. Thus, uninsured deceased patients (or
amily members who donate on their behalf) can donate
heir hearts although they themselves would not have had
ccess to receive a transplant had they needed one.
We believe this situation to be untenable and to violate
ne of the basic tenets of bioethics, the principle of justice,
ommonly defined in health care as the equitable allocation
f resources (3), but herein used more specifically to describe
he general inequity inherent in asking a group of people to
ontribute to a pool of resources not generally available to
hem. Although inequities in the health care system related
o SES are widespread, organ transplantation is unique
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May 3, 2005:1388–91 Insurance and Cardiac Transplantationecause of its dependence on the willingness of other
embers of society to donate willingly their own organs or
he organs of their loved ones. The purpose of this paper is
o review various aspects of this complex issue in an effort to
urther a national dialogue on ways to ensure an equitable
ystem of heart allocation in the U.S., recognizing that
any of the points discussed are equally relevant to trans-
lantation of other solid organs such as liver and lung.
URRENT STATUS OF HEART TRANSPLANTATION
he decision to register a patient as a candidate on the
nited Network of Organ Sharing waiting list is made by
ransplant cardiologists and surgeons at the patient’s treat-
ng hospital. Many factors influence this decision and most
ocus on the severity of the patient’s cardiac illness and
ossible contraindications to transplant (4). However, trans-
lant centers also consider a prospective transplant recipient’s
bility to pay for the procedure, for lifelong medications, and
or follow-up care. The financial demands associated with
ransplantation are considerable. The estimated first year costs
or heart transplant are $391,000, and subsequent annual
osts, estimated to be $21,200 in 1996, would be $35,200
er year if adjusted using the consumer price index (5,6). If
atients are uninsured or underinsured and do not have
ther means to pay for the procedure and costs of follow-up,
egardless of the likelihood of a successful transplant, they
sually will not be placed on a transplant list (7–10).
UMBER OF UNINSURED WITH HEART
AILURE AND OF UNINSURED DONORS
t is not known how many people in our country are in need of
heart transplant but are excluded due to a lack of funds. To
ur knowledge, there is no prospective registry that tracks such
atients, and referral bias (i.e., physicians not referring unin-
ured patients for transplant evaluation and hospitals or trans-
lant centers not accepting transfer of uninsured ESHF pa-
ients) hampers retrospective gathering of such data. However,
t is possible to create an estimate using recent statistics released
rom the Census Bureau for 2002, which reveal that 43.6
illion (15.2% of the population) (11) are uninsured. Between
he ages of 45 to 64 years, the most common age group to
eceive a heart transplant, 13.1% are uninsured. Another 31
illion people are underinsured (12,13).
Abbreviations and Acronyms
DHHS  Department of Health and Human Services
ESHF  end-stage heart failure
ESRD  end-stage renal disease
NOTA  National Organ Transplant Act
OPTN  Organ Procurement and Transplantation
Network
SES  socioeconomic status
UAGA  Uniform Anatomical Gift ActThe Census Bureau data provides the crude estimate that D3% to 15% of patients with ESHF who could benefit from
ransplantation do not have insurance to pay for this procedure.
owever, this estimate may be too low because patients with
SHF have impaired functional capacity and may be fre-
uently hospitalized, factors that would hinder their ability to
aintain employment and obtain employer-sponsored health
nsurance. Conversely, this estimate may be overinflated, as
atients without health insurance have limited access to pre-
entive care and may have increased rates of other chronic
edical conditions that may exclude them from transplanta-
ion. Therefore, prospective data are needed to accurately
etermine the number of patients not considered for cardiac
ransplantation solely due to a lack of funds.
The number of organ donors in our country who are
ninsured is also unknown. Using the Census Bureau estimate,
ne might surmise that, of 2,350 hearts donated yearly (14),
pproximately 14% (n 330) would be donated by uninsured
onors. To refine this estimate, we queried Siminoff’s National
tudy of Family Consent to Organ Donation database. This
tudy examined the experiences and attitudes of 420 families
ho were asked to donate organs in Ohio and Pennsylvania
15). Health insurance status of the potential donor was
etermined retrospectively by a review and analysis of medical
ecords. Characteristics of the 298 donors are shown (Table 1).
total of 23% of the donors were uninsured suggesting, if
hese data are representative of the national experience, that
early one in four donated hearts in this country come from
ninsured individuals.
BILITY TO PAY FOR TRANSPLANT—LEGISLATION
he federal government has visited the issue of ability to pay
or transplant on several occasions. In 1986, a federally ap-
ointed task force, convened in accordance with section 104(c)
f the 1984 National Organ Transplant Act (NOTA) (16),
ecommended that, “[a]ll patients should have access to all
fficacious organ transplantation procedures regardless of abil-
ty to pay . . .” (2). The task force cited two arguments in
upport of its recommendation: 1) organs are a public resource,
onated altruistically by members of the public with the
xpectation that they will be distributed in an equitable
anner; and 2) society has chosen to fund comparable proce-
ures, most notably the Medicare End Stage Renal Disease
ESRD) program, and that to deny similar care for those in
eed of other organ transplants based solely on inability to pay
ould be inequitable (2,17).
able 1. Characteristics of Donors in Siminoff’s (15) National
tudy of Family Consent to Organ Donation (n  298)
ge, yrs 36  20
hite 263 (88)
ale gender 188 (63)
nsurance status
Commercial 152 (51)
Government 78 (26)
No insurance 68 (23)ata are shown as mean  SD or number (%).
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Insurance and Cardiac Transplantation May 3, 2005:1388–91In 1998, then Secretary of the Department of Health and
uman Services (DHHS), Donna Shalala, proposed a Final
ule for the NOTA governing the operation of the Organ
rocurement and Transplantation Network (OPTN) (9). In
ection 121.4(3) of the proposed Final Rule, Secretary
halala would have required the OPTN Board of Directors
o develop policies that reduce inequities resulting from
ES. The proposed Final Rule engendered much public
ebate. Many were concerned that if hospitals were required
o fund organ transplantation for those unable to pay,
ransplant programs might be forced to close for fear of
egatively impacting hospital finances (8,9). In response to
hese criticisms, the DHHS noted that the Secretary merely
equired that the OPTN “consider” policies designed to
educe inequities in the allocation of organs for transplant
9). An Institute of Medicine report released shortly there-
fter, although principally focused on geographic disparities
n organ allocation, concluded that low SES was a barrier to
eing listed for organ transplantation (18). An amended
inal Rule, effective March 16, 2000 (19), required that the
egistration fee, approximately $500, be waived if it posed a
nancial burden and that the OPTN create procedures for
ransplant hospitals to make “reasonable efforts” to obtain
unds from all available sources.
In sum, although the federal government has acknowledged
he inequities of the status quo, little governmental action has
een taken to date, undoubtedly reflecting the potential finan-
ial consequences involved in expanding access to organ trans-
lants to those without funds. Nevertheless, in the context of
resent governmental efforts to expand the donor pool (20),
hich likely will increase the absolute if not proportional
umber of uninsured donors, we believe there is increasing
mpetus for the government to address this inequity.
BILITY TO PAY FOR TRANSPLANT—RELATIONSHIP
O THE CONSENT PROCESS FOR ORGAN DONATION
he Uniform Anatomical Gift Act (UAGA) (1987) (21)
stablished the driver’s license or donor card system used by
any organ donors to indicate their intent to donate. Under
he provisions of the UAGA and similar state laws, this
xpression of intent is sufficient, and the family of the
eceased need not be consulted. Nevertheless, families are
outinely consulted before organs are procured, in large part
o avoid insensitivity to grieving families and as part of the
ormative expectation that family consent will be obtained.
n recent years, 11 states have attempted to increase organ
onation rates by enacting “first person consent” laws (22).
nder these laws, if the deceased is registered as a donor
nd has signed a consent document, families will be in-
ormed of their loved one’s intent but will no longer be
onsulted for their consent before the donation.
Extensive efforts are employed to ensure that families are
ell informed and comfortable with the donation process
23). Nevertheless, it is likely that such discussions do not
ddress the lack of access to organ transplantation endured ty uninsured and underinsured patients. A review of the
idely adopted “Model Elements of Informed Consent for
rgan and Tissue Donation” (24) revealed no mention of
he SES of potential recipients. We recognize that some in
he medical community will not consider it necessary to
iscuss this issue as part of the informed consent process,
hough we would argue that it should be openly discussed,
specially when the potential donor is uninsured.
OTENTIAL IMPACT ON RATES OF
RGAN DONATION AMONG AFRICAN AMERICANS
frican Americans agree to donate their organs at about half
he rate of whites (23) for a variety of reasons including more
ommonly believing that the resources devoted to organ
ransplantation should be redirected toward other medical
eeds (25) and that the system of organ allocation in the U.S.
s unfair (15,25,26). Prior studies have found that a major
arrier to access to organ (e.g., kidney) transplantation among
thnic minorities with lower SES is placement on the trans-
lant list (18,27). Because African Americans are more likely
han whites to be uninsured (28), the funding requirement for
lacement on the transplant list affects African Americans
isproportionately, and undoubtedly contributes to their per-
eption of an unfair system. We believe that removing the
resent funding requirement for transplant, while rectifying an
nacceptable inequity in the current system, has the potential to
xpand the overall donor pool as members of economically
isadvantaged segments of the population, including African
mericans, may be more willing to donate their organs if they
erceive the allocation system to be equitable. In the absence of
ata, however, this hypothesis remains speculative.
OTENTIAL COSTS OF CARDIAC
RANSPLANTATION IN UNINSURED PATIENTS
detailed review of the costs that might be associated with
n indigent heart transplant program and possible funding
ources for such a program are beyond the scope of this
aper. Nevertheless, to begin the discussion, we provide an
stimate of the costs of funding 330 heart transplants, a
roportion (14%) of annual heart transplants equal to the
roportion of uninsured donors. The initial year would cost
130 million (6) while the cost of follow-up over the next
ve years for these initial 330 patients would be approxi-
ately $60 million (5). The costs would compound as more
nd more uninsured patients were enrolled in the program.
lthough it may be argued that such costs would be prohibi-
ive, it is important to recognize that the total costs associated
ith heart transplantation presently represent 1% of the
$40 billion spent annually for heart failure (29).
One potential source of funding for such a program
ould be the federal government. Given that the Medicare
rogram presently pays for kidney transplantation in those
ith ESRD, it would seem equitable that a similar mech-
nism could be used to pay for cardiac transplantation in
hose with ESHF. Such a governmentally sponsored pro-
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May 3, 2005:1388–91 Insurance and Cardiac Transplantationram would have the additional benefits of allowing recip-
ents to return to work without fear of losing disability-
elated health insurance and minimizing employer concerns
egarding health care liabilities.
ALL FOR GOVERNMENTAL REVIEW:
STABLISHMENT OF A REGISTRY AND TASK FORCE
he interplay between lower SES as manifested by lack of
ealth insurance, comorbidities including a previous history
f noncompliance, and poorer outcomes after transplanta-
ion is complex (30–33). However, to maximize the benefits
ealized from donated hearts, all patients with ESHF who do
ot have medical contraindications and are willing and able to
omply with the demands of the posttransplant regimen
hould be considered as potential recipients irrespective of
nsurance or financial status. As a first step, a registry should be
reated of all patients otherwise eligible for cardiac transplan-
ation denied such based solely on inability to pay.
Further, we hope this paper will spark debate on this subject
nd will lead to a government-sponsored, multidisciplinary
ask force that addresses the inequities in the present system.
roviders, payers, transplant physicians and teams, transplant
ecipients, and donor families should be involved. The follow-
ng issues need to be addressed: 1) the number of patients
urrently not eligible for transplant because of insufficient
unding and the number of uninsured donors; 2) disclosure
equirements for informed consent; and 3) proposals to en-
ance equitable access to cardiac transplantation.
eprint requests and correspondence: Dr. Mark H. Drazner,
niversity of Texas Southwestern Medical Center, 5323 Harry
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